Eucrates Biomedical Acquisition Corp. Annual Net Cash Provided by (Used in) Financing Activities in USD for 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Eucrates Biomedical Acquisition Corp. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate for 2022.
  • Eucrates Biomedical Acquisition Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $250K.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$92.6M Jan 1, 2022 Dec 31, 2022 10-K 2023-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.